Updated:
Novo Holdings A/S
Novo Holdings A/S is a asset manager based in Singapore, Singapore, founded 1999; the Altss profile covers its classification, headquarters, registration, AUM...
Novo Holdings A/S
Novo Holdings A/S is a SEC-registered investment adviser in Singapore, registered since 2020. It is based in Singapore.
General information
Firm type
Asset Manager
Year founded
1999
Location
Region
Europe
Country
Denmark
City
Singapore, Singapore
Corporate office
Hellerup, Denmark
Additional offices
Boston, United States · London, United Kingdom · San Francisco, United States · Singapore, Singapore · Shanghai, China
Principals
Kasper Videbæk
Chief Investment Officer, Novo Holdings
Henrik Gürtler
Senior Partner, Novo Holdings
Sector focus
Frequently asked questions
Who controls Novo Holdings?
Novo Holdings is wholly owned by the Novo Nordisk Foundation, which controls the majority voting rights in Novo Nordisk A/S and Novozymes A/S. The foundation's board appoints the board of Novo Holdings. This structure separates the philanthropic mission of the foundation from the commercial asset management operations.
Does Novo Holdings operate as a single family office?
No. Novo Holdings is a professionally managed investment company acting as the asset management arm of the Novo Nordisk Foundation. It is not a family office for any individual; rather, it manages the foundation's portfolio with a fiduciary duty to support the foundation's charitable purposes.
What is the investment strategy of Novo Holdings?
The firm allocates capital across private equity, public equities, and venture capital, with a particular focus on life sciences and healthcare. It also invests in climate tech, industrials, and technology. The private equity team makes direct investments and fund commitments, while the public equities team manages listed holdings including the core Novo Nordisk and Novozymes stakes.
Does Novo Holdings invest in venture capital?
Yes, Novo Holdings has a dedicated venture capital arm that invests in early-stage life sciences and health technology companies. It has a track record of backing European biotech and health startups, often leading or participating in Series A and B rounds.
What is the relationship between Novo Holdings and the Novo Nordisk Foundation?
The Novo Nordisk Foundation is the sole shareholder of Novo Holdings. The foundation uses the returns generated by Novo Holdings' investment portfolio to fund philanthropic activities, primarily in medical research and health. Novo Holdings manages the foundation's assets, including the controlling stakes in Novo Nordisk and Novozymes.
How large is Novo Holdings' portfolio?
As of 2025, Novo Holdings reported approximately $108 billion in assets under management (per the firm). This includes both the concentrated holdings in Novo Nordisk and Novozymes as well as a diversified portfolio of private and public investments.
Where does Novo Holdings invest geographically?
The firm has investment offices in Hellerup (headquarters), Boston, London, San Francisco, Singapore, and Shanghai. Its investment focus is global, with a significant presence in Europe and North America, and growing activity in Asia.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: